NATERA, INC. Deferred Costs and Other Assets
NATERA, INC. (NTRA) had Deferred Costs and Other Assets of $2.80 million as of 2016-09-30, per its 10-Q filed 2016-11-14.
Discontinued › Notes
us-gaap:DeferredCostsAndOtherAssets · last filed 2016-11-14
- 2016-09-30: Deferred Costs and Other Assets $2.80M.
- 2016-06-30: Deferred Costs and Other Assets $3.00M.
| Period end | Deferred Costs and Other Assets |
|---|---|
| 2016-09-30 | $2.80M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $3.00M 10-Q · filed 2016-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |